The Deal
Saturday, November 21, 
7:30 am

Martin Lipton serves poison pill to activists

  Share     E-Mail    Discussion    Print Story
Martin_Lipton.jpgThe creme de la creme of corporate lawyers, Martin Lipton, founding partner of Wachtell, Lipton, Rosen & Katz and inventor of the poison pill, crammed a different kind of poison pill down activist hedge funds' throats as he lashed out at what he believes is a short-term and potentially short-sighted investment style.

Lipton along with Roel Campos, partner in charge of Cooley Godward Kronish LLP's Washington office, keynoted a conference on Tuesday held by the New York Bar Association entitled "Counseling the Board of Directors During the New Age of Activist Shareholders." 

Continue reading below

Also on Dealscape

Shortly after a cordial introduction by conference host Jared Landaw, senior managing director and general counsel of activist hedge fund Barington Capital Group LP, Lipton began to bite the hand that introduced him. He said that one of the most significant problems caused by activists is their method of attempting to force companies to focus on short-term stock gains rather than long-term value, which could entail pushing for share buybacks or possible special dividends to create a quick profit for shareholders.

Activists can interrupt a company's operations before even targeting a company if that company operates in a sector that has been attacked by activists, Lipton said. "The near possibility of activist investors' attacks on a company" has significant impact on its operations, he added. 

However, not all activists are bad in Lipton's views -- just the hedge funds. Lipton said there are responsible activist investors, but added that these are "not necessarily hedge funds." One responsible activist he cited was Ralph Whitworth's Relational Investors LLC, which he said doesn't press for quick changes.

All the while Landaw sat next to Lipton and just grinned and bore it as any gracious host would. His diplomatic efforts and reverence for Lipton extended beyond the panelist dais. Landaw was overheard saying to an attendee during a break that Lipton respectfully stated his opinions.

Landaw could only hold his tongue for so long, however. During the concluding session entitled "Shareholder Activism and the Responsibility of the Board from the Hedge Funds Perspective," he defended his fund and his peers in saying that activist investing is not a matter of short-term versus long-term. "It's a question," he said, "of alternatives." He did specifically address Lipton in his retort. He added that comments that activist hedge funds are short term-focused tend to be made by CEOs that have mismanaged companies for quite some time. Landaw said that Barington tends to employ a longer-term private equity-like two-to-five-year investment strategy. - Michael Rudnick





Post a comment





The Deal Pipeline

Deal Video


Inside The Deal: Avaya Inc.'s Mohamad Ali on the company's next target.


More video...

Crisis On Wall Street
Technology
Deals of The Decade

Community

Industry Insight

Managing your shareholder base

Growth companies and their PE sponsors should be wary of the pitfalls that arise when they layer on tiers of preferred stock.


Industry Insight

Easing the stress of distressed M&A

Corporate buyers face numerous complexities when trying to identify the right moment to purchase a distressed asset.


Editor's Note

Editor's letter: Nov. 16, 2009

Beneath the veneer of Wall Streeters beats the same heart, stirred by the same determinants of behavior.


footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg footspacer.jpg


©Copyright 2009, The Deal, LLC. All rights reserved. Please send all technical questions, comments or concerns to the Webmaster.